Biomarkers for personalized medicine in GI cancers.
Explore this paper's citation graph
Summary
This review focuses on the most pertinent prognostic and predictive biomarkers used in the clinical management of gastric, pancreas, and colon cancer.
- Type
- article
- Published
- 2015-11-01
- Cited by
- 13
- References
- 205
- OpenAlex
- https://openalex.org/W26054566
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:21981406
Keywords
Humanities, Medicine, Philosophy
References
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
- Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool.
- Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
- Cancer treatment and survivorship statistics, 2016
- Pancreatic Ductal Adenocarcinoma: A Review of Immunologic Aspects
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
- Biosynthesis of the protein encoded by the c-met proto-oncogene.
- Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis.
- Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation.
- Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.
- Presence of Two Signaling TGF-β Receptors in Human Pancreatic Cancer Correlates with Advanced Tumor Stage
- Pathways of chromosome alteration in human epithelial cancers.
- Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- Randomized comparison of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment of KRAS-wildtype metastatic colorectal cancer: German AIO study KRK-0306 (FIRE-3).
- PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors.
- The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
- Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
- Adjuvant therapy for stage II colon cancer: prognostic and predictive markers.
- Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models
Cited by
- Function analysis of rs9589207 polymorphism in miR-92a in gastric cancer
- Survival of Stomach Cancer Cases in Khon Kaen, Thailand 2000-2012.
- The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system
- Gastric carcinoma in canines and humans, a review
- Shall we Sample Every Pancreatic Mass
- Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer
- Nanotheranostics: Their role in hepatocellular carcinoma.
- Identification of the RP11-21C4.1/SVEP1 gene pair associated with FAT2 mutations as a potential biomarker in gastric cancer
- Novel therapeutic approaches for gastrointestinal malignancies
- Role of Selected Transcription Factors in Pancreatic and Colorectal Cancer Growth and Metastasis
- Pancreatic Cancer Biomarkers
- How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?
- Leveraging dogs with spontaneous cancer to advance drug development
Related papers
No related papers recorded.